- Home
- EYPT vs CEVA Comparison
EYPT vs CEVA Comparison
Compare EYPT & CEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EYPT
- CEVA
- Stock Information
- Founded
- EYPT 1987
- CEVA 1999
- Country
- EYPT United States
- CEVA United States
- Employees
- EYPT N/A
- CEVA N/A
- Industry
- EYPT Biotechnology: Laboratory Analytical Instruments
- CEVA Semiconductors
- Sector
- EYPT Industrials
- CEVA Technology
- Exchange
- EYPT Nasdaq
- CEVA Nasdaq
- Market Cap
- EYPT 594.5M
- CEVA 666.8M
- IPO Year
- EYPT 2005
- CEVA 2000
- Fundamental
- Price
- EYPT $8.12
- CEVA $33.38
- Analyst Decision
- EYPT Strong Buy
- CEVA Strong Buy
- Analyst Count
- EYPT 8
- CEVA 3
- Target Price
- EYPT $27.29
- CEVA $36.00
- AVG Volume (30 Days)
- EYPT 918.1K
- CEVA 233.1K
- Earning Date
- EYPT 11-07-2024
- CEVA 11-07-2024
- Dividend Yield
- EYPT N/A
- CEVA N/A
- EPS Growth
- EYPT N/A
- CEVA N/A
- EPS
- EYPT N/A
- CEVA N/A
- Revenue
- EYPT $45,713,000.00
- CEVA $101,878,000.00
- Revenue This Year
- EYPT N/A
- CEVA $9.88
- Revenue Next Year
- EYPT N/A
- CEVA $9.91
- P/E Ratio
- EYPT N/A
- CEVA N/A
- Revenue Growth
- EYPT 7.50
- CEVA N/A
- 52 Week Low
- EYPT $7.21
- CEVA $16.02
- 52 Week High
- EYPT $30.99
- CEVA $33.34
- Technical
- Relative Strength Index (RSI)
- EYPT 41.68
- CEVA 66.41
- Support Level
- EYPT $7.21
- CEVA $31.97
- Resistance Level
- EYPT $8.21
- CEVA $33.34
- Average True Range (ATR)
- EYPT 0.49
- CEVA 1.14
- MACD
- EYPT -0.02
- CEVA 0.05
- Stochastic Oscillator
- EYPT 42.82
- CEVA 92.51
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.
About CEVA CEVA Inc.
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.